Literature DB >> 7212812

Changes in serum total creatine phosphokinase (CPK) and its isoenzymes caused by experimental ligation of the superior mesenteric artery.

G M Graeber, P J Cafferty, M J Reardon, C P Curley, N B Ackerman, J W Harmon.   

Abstract

The changes in serum total CPK and its isoenzymes have not been delineated in acute mesenteric infarction. As measurement of serum CPK levels could conceivably be a useful diagnostic test for bowel infarction, this experiment was performed to assess changes in serum CPK levels in bowel infarction in dogs, using sham operation and talc peritonitis as controls. Laparotomies were performed in 20 dogs, and each was as signed randomly to one of three groups: those having laparotomy (LAP), talc peritonitis (PER), and superior mesenteric artery infarction (MAI). Mixed venous blood samples were obtained from all subjects for 30 hours after surgery. All animals were killed, and complete autopsies were performed. Confirmation of infarction and determination of its extent were obtained through both gross and microscopic examination of the gut in canines subjected to arterial infarction. Total serum CPK levels were determined by spectrophotometric analysis. Agarose gel electrophoresis was used to determine the levels of each of the isoenzymes. Significant elevations of CPK and CPK-MM occurred nine hours after injury. CPK-BB reached maximum elevation by six hours, while CPK-MB did not reach its maximum until 24 hours after injury. From data in the study we conclude that total CPK and its isoenzymes become elevated in the serum of canines subjected to experimental superior mesenteric artery infarction. That CPK-BB elevations peak in the first 12 hours after injury and CPK-MB in the second 12 hours after injury may be of particular diagnostic significance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7212812      PMCID: PMC1345104     

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  12 in total

1.  Creatine kinase isoenzyme patterns in human tissue obtained at surgery.

Authors:  S H Tsung
Journal:  Clin Chem       Date:  1976-02       Impact factor: 8.327

2.  Appearance of creatine kinase BB isoenzyme in the serum of a patient suffering from infarction of the colon.

Authors:  G R Doran
Journal:  Clin Chim Acta       Date:  1979-03-15       Impact factor: 3.786

3.  Evaluation of a new procedure for measuring serum creatine kinase activity.

Authors:  J H Wilkinson; B Steciw
Journal:  Clin Chem       Date:  1970-05       Impact factor: 8.327

4.  An improved procedure for serum creatine phosphokinase determination.

Authors:  S B Rosalki
Journal:  J Lab Clin Med       Date:  1967-04

5.  Quantification of serum creatine phosphokinase isoenzyme activity.

Authors:  R Roberts; P D Henry; S A Witteeveen; B E Sobel
Journal:  Am J Cardiol       Date:  1974-05-06       Impact factor: 2.778

6.  The surgical management of acute occlusion of the superior mesenteric artery.

Authors:  L W Ottinger
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

7.  An improved basis for enzymatic estimation of infarct size.

Authors:  R Roberts; P D Henry; B E Sobel
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

8.  The detection of CPK1 (BB) in serum. A summary of sixteen cases.

Authors:  M Itano
Journal:  Am J Clin Pathol       Date:  1976-03       Impact factor: 2.493

9.  Serum creatine phosphokinase: evaluation of a commercial spectrophotometric method.

Authors:  J W Hess; R P MacDonald; G J Natho; K J Murdock
Journal:  Clin Chem       Date:  1967-11       Impact factor: 8.327

10.  Specificity of elevated serum MB creatine phosphokinase activity in the diagnosis of acute myocardial infarction.

Authors:  R Roberts; K S Gowda; P A Ludbrook; B E Sobel
Journal:  Am J Cardiol       Date:  1975-10-06       Impact factor: 2.778

View more
  14 in total

1.  An experimental evaluation of the lactate concentration following mesenteric ischemia.

Authors:  Yoshihiko Kurimoto; Nobuyoshi Kawaharada; Toshiro Ito; Masayuki Morikawa; Tetsuya Higami; Yasufumi Asai
Journal:  Surg Today       Date:  2008-09-27       Impact factor: 2.549

2.  Serum enzyme levels during intestinal ischemia.

Authors:  J S Thompson; L E Bragg; W W West
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

3.  Prognostic factors in patients with acute mesenteric ischemia.

Authors:  Doğan Yıldırım; Adnan Hut; Cihad Tatar; Turgut Dönmez; Muzaffer Akıncı; Mehmet Toptaş
Journal:  Turk J Surg       Date:  2017-06-01

4.  Inferior mesenteric venous sampling, pulse oximetry, and assessment of colonic perfusion during aortic aneurysm surgery.

Authors:  C P Delaney; N F Couse; D Mehigan; T V Keaveny
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

5.  Value of the serum I-FABP level for diagnosing acute mesenteric ischemia.

Authors:  Murat Güzel; Erdoğan Mütevelli Sözüer; Ömer Salt; İbrahim İkizceli; Okhan Akdur; Cevat Yazıcı
Journal:  Surg Today       Date:  2013-12-17       Impact factor: 2.549

6.  Systemic and colonic venous plasma biochemical alterations in horses during low-flow ischemia and reperfusion of the large colon.

Authors:  R M Moore; W W Muir; B R Rush
Journal:  Can J Vet Res       Date:  1998-01       Impact factor: 1.310

Review 7.  Creatine kinase in the dog: a review.

Authors:  M Aktas; D Auguste; H P Lefebvre; P L Toutain; J P Braun
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

8.  Acute mesenteric ischemia.

Authors:  Y Mishima
Journal:  Jpn J Surg       Date:  1988-11

9.  Creatine kinase isoenzymes in the diagnosis of intestinal infarction.

Authors:  M W Fried; U K Murthy; S R Hassig; J Woo; R P Oates
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

10.  D-dimer levels in the prediction of the degree of intestinal necrosis of etrangulated hernias in rats.

Authors:  Nazif Zeybek; Fahrettin Yildiz; Levent Kenar; Yusuf Peker; Bülent Kurt; Turker Cetin; Tayfun Ide; Turgut Tufan
Journal:  Dig Dis Sci       Date:  2007-11-21       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.